Nature Biotechnology‘s First Rounders podcast is a series of conversations with founders, financers and developers from biotech’s past, present and future.
Hosted on Acast. See acast.com/privacy for more information.
php/*
Nature Biotechnology‘s First Rounders podcast is a series of conversations with founders, financers and developers from biotech’s past, present and future.
Hosted on Acast. See acast.com/privacy for more information.
Copyright: © 2019 Springer Nature 878632
Daphne Zohar is the founder, CEO and managing partner at PureTech, a venture creation company with a new approach to building biotechs, and she sits on the board of several life science firms. Her conversation with Nature Biotechnology covers starting her first company (in high school), the usefulness of Bioentrepreneur courses, and women in venture capital. (Updated February 6, 2015).
Hosted on Acast. See acast.com/privacy for more information.
Mary Tanner details the Amgen-Immunex buyout, defines 'wildcatting' and suggests the years in which children most need a parent around the house.
Hosted on Acast. See acast.com/privacy for more information.
Anthony Davies discusses the past, present and future of stem cell therapies.
Hosted on Acast. See acast.com/privacy for more information.
Julian Davies takes us through his long research career in Madison, Wisconsin; Paris and Geneva. He also discusses wrecking his motorcycle and how he met his wife.
Hosted on Acast. See acast.com/privacy for more information.
Leroy Hood talks through the founding of Applied Biosystems, the beginnings of the Human Genome Project and what drew him to mountain climbing.
Hosted on Acast. See acast.com/privacy for more information.
Nature Biotechnology talked to West about his initial love for physics, scoring the first funding for Geron and the future of regenerative medicine.
Hosted on Acast. See acast.com/privacy for more information.
Nature Biotechnology spoke to Harvey Berger about developing Iclusig, the difference between managing a patient's health and running a company, and how a public entity deals with bad news.
Hosted on Acast. See acast.com/privacy for more information.
George Yancopoulos talks about the scientific foundation at Regeneron, upholding the family name and giving back through teaching.
Hosted on Acast. See acast.com/privacy for more information.
Una Ryan discusses the biotech East Coast vs. West; life in Oxford, UK; and her initial foray into industry via a job at Monsanto.
Hosted on Acast. See acast.com/privacy for more information.
William A. Haseltine talks about his time at HGS, the future of genomics in drug discovery and how innovation might be funded going forward.
Hosted on Acast. See acast.com/privacy for more information.